- Home
- NNNN vs REFI Comparison
NNNN vs REFI Comparison
Compare NNNN & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- REFI
- Stock Information
- Founded
- NNNN 2021
- REFI 2021
- Country
- NNNN Germany
- REFI United States
- Employees
- NNNN N/A
- REFI N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- REFI Real Estate Investment Trusts
- Sector
- NNNN Health Care
- REFI Real Estate
- Exchange
- NNNN Nasdaq
- REFI Nasdaq
- Market Cap
- NNNN 267.7M
- REFI 291.9M
- IPO Year
- NNNN 2025
- REFI 2021
- Fundamental
- Price
- NNNN $6.43
- REFI $14.97
- Analyst Decision
- NNNN
- REFI Strong Buy
- Analyst Count
- NNNN 0
- REFI 3
- Target Price
- NNNN N/A
- REFI $20.00
- AVG Volume (30 Days)
- NNNN 28.8K
- REFI 100.4K
- Earning Date
- NNNN 01-01-0001
- REFI 05-07-2025
- Dividend Yield
- NNNN N/A
- REFI 13.77%
- EPS Growth
- NNNN N/A
- REFI N/A
- EPS
- NNNN 0.06
- REFI 1.88
- Revenue
- NNNN $8,185,146.00
- REFI $56,790,054.00
- Revenue This Year
- NNNN N/A
- REFI $17.87
- Revenue Next Year
- NNNN N/A
- REFI N/A
- P/E Ratio
- NNNN $118.17
- REFI $7.96
- Revenue Growth
- NNNN 21.95
- REFI 4.68
- 52 Week Low
- NNNN $5.18
- REFI $12.76
- 52 Week High
- NNNN $7.82
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- REFI 62.01
- Support Level
- NNNN N/A
- REFI $14.50
- Resistance Level
- NNNN N/A
- REFI $14.81
- Average True Range (ATR)
- NNNN 0.00
- REFI 0.27
- MACD
- NNNN 0.00
- REFI 0.12
- Stochastic Oscillator
- NNNN 0.00
- REFI 90.91
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.